Adverse events in apheresis: An update of the WAA registry data
about
Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures.Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.Membrane therapeutic plasma exchange with and without heparin anticoagulation.
P2860
Adverse events in apheresis: An update of the WAA registry data
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Adverse events in apheresis: An update of the WAA registry data
@ast
Adverse events in apheresis: An update of the WAA registry data
@en
Adverse events in apheresis: An update of the WAA registry data
@nl
type
label
Adverse events in apheresis: An update of the WAA registry data
@ast
Adverse events in apheresis: An update of the WAA registry data
@en
Adverse events in apheresis: An update of the WAA registry data
@nl
prefLabel
Adverse events in apheresis: An update of the WAA registry data
@ast
Adverse events in apheresis: An update of the WAA registry data
@en
Adverse events in apheresis: An update of the WAA registry data
@nl
P2093
P1476
Adverse events in apheresis: An update of the WAA registry data
@en
P2093
A Griskevicius
A Wahlström
B Ramsauer
B Stegmayr
C G Axelsson
P356
10.1016/J.TRANSCI.2016.01.003
P407
P50
P577
2016-01-08T00:00:00Z